Skip to main content
James Rosenbaum, MD, Rheumatology, Portland, OR

JamesToddRosenbaumMD

Rheumatology Portland, OR

Senior Vice-President for Research, Corvus Pharmaceuticals, Burlingame, CA.; Richard Chenoweth Professor Emeritus, Legacy Devers Eye Clinic, Portland, OR.

Dr. Rosenbaum is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rosenbaum's full profile

Already have an account?

  • Office

    3181 SW Sam Jackson Park Rd
    L467ad
    Portland, OR 97239
    Phone+1 503-494-5023
    Fax+1 503-494-6875

Summary

  • I am a board certified rheumatologist with special expertise in ocular inflammatory diseases. I am currently employed full-time as the Senior Vice-President for Research at Corvus Pharmaceuticals. I see patients one half day per week at Legacy Devers Eye Clinic in Portland, OR. This clinic is a joint undertaking with a retina specialist, Sirichai Pasadhika, and provides care for patients with ocular inflammatory diseases.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Allergy and Immunology, 1978 - 1981
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1975 - 1978
  • Yale School of Medicine
    Yale School of MedicineClass of 1975
  • Harvard University
    Harvard UniversityAB, Social Relations, Magna Cum Laude, Phi Beta Kappa, 1967 - 1971

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 1985 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Manfred Zierhut Teaching Award International Uveitis Study Group, 2024
  • Innovative Research Award Rheumatology Research Foundation, American College of Rheumatology, 2018-2020, 2022-2024
  • Distinguished Service Award American College of Rheumatology, 2022
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Community Profiling of the Urinary Microbiota: Considerations for Low-Biomass Samples  
    Rahel Nardos, James T Rosenbaum, Nature

Other

Press Mentions

  • ITK Inhibition with Soquelitinib Induced Switching of Proinflammatory Th
    ITK Inhibition with Soquelitinib Induced Switching of Proinflammatory ThJuly 25th, 2024
  • James Rosenbaum Presented the Distinguished Service Award by the American College of Rheumatology
    James Rosenbaum Presented the Distinguished Service Award by the American College of RheumatologyNovember 14th, 2022
  • The Rising Toll of Autoimmune Diseases in Older People
    The Rising Toll of Autoimmune Diseases in Older PeopleAugust 10th, 2021
  • Join now to see all

Grant Support

  • Ophthalmology Core FacilityNational Eye Institute1995–2012
  • Understanding Uveitis In A Multi-System Disease Model Of SpondyloarthropathyNational Eye Institute2011
  • Gene Expression In Nonspecific Orbital Inflammatory DiseaseNational Eye Institute2011
  • Endotoxin-Induced Uveitis RevisitedNational Eye Institute2009–2010
  • Four Dimensional Imaging Of The Immune Response In VivoNational Eye Institute1999–2010
  • Uveitis Gene-Expression ProfilingNational Eye Institute2005–2008
  • Chemotactic Factors In Animal Models Of UveitisNational Eye Institute1986–2008
  • Immunology/Molecular Biology Training In OphthalmologyNational Eye Institute1991–2007
  • Uveitis Gene-Expressoin ProfilingNational Eye Institute2006
  • "Remicade" In The Management Of Vision-Threatening UveitisNational Center For Research Resources2004–2005
  • Anterior Uveal Dendritic CellsNational Eye Institute2001–2004
  • Opthalmology Core FacilityNational Eye Institute2000–2004
  • Four Dimentional Imaging Of The Immune Response In VivoNational Eye Institute2000–2003
  • Chemotactic Factors In Models Of UveitisNational Eye Institute1994–2003
  • Ophthalmology Core Facility SupplementNational Eye Institute2001
  • Utility Of Intravenous Immunoglobulin In The Treatment Of UveitisNational Center For Research Resources1997–2001
  • Endotoxin Induced UveitisNational Eye Institute1985–2000
  • Core--Tissue CultureNational Eye Institute1997–1999
  • Endotoxin-Induced UveitisNational Eye Institute1987–1996
  • Growth Factors In Proliferative VitreoretinopathyNational Eye Institute1989–1992

Professional Memberships

Industry Relationships

  • Senior VP, Corvus Pharmaceuticals2022 - Present